The World Health Organization (WHO) has approved the emergency use of the Moderna’s vaccine. The WHO said in a statement on Friday. Qatar-based Al Jazeera reported the news.
The Moderna’s vaccine has been approved by the World Health Organization as the fifth vaccine to expedite vaccination activities in the country. However, in January this year, the WHO’s expert advisory group (SAGE) approved the emergency use of the modern vaccine for those 18 years of age or older.
Mariangela Simao, WHO’s assistant director general, said: “It was important to keep the vaccine supply ready as there were problems with other vaccine manufacturers, including India, one of the providers of the vaccine fund Covax, which aims to supply developing countries around the world.”
The WHO said in a statement that it wanted to make available access to medicines, vaccines and tests for emergencies.
Meanwhile, Moderna announced this week that they will produce 300 million dose vaccines by 2022. They also announced plans to increase production capacity for this purpose.
In late 2020, Pfizer-Biontech MRNA vaccine in the same category as Modern was approved for emergency use by the WHO for the first time. One by one, the World Health Organization approved the emergency use of the AstraZeneca, Serum Institute and Johnson & Johnson vaccines.
The Chinese-made coronavirus vaccine Sinopharm and Sinovac are still under review. The UN health agency may announce the decision next week.